Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Anticancer Therapies Congress 2027

offers an in‑depth look at emerging anticancer agents, novel combinations and biomarker‑driven strategies that are transforming outcomes for patients with cancer. For academic researchers and clinicians ESMO TAT 2027 is the place to discuss...

3rd Global Summit on Heart and Cardiovascular Care 2026

in advancing cardiovascular health. Continuing its legacy of excellence, Heart Congress 2026 will serve as a vibrant platform for cross-disciplinary dialogue on the latest innovations in cardiovascular research, digital health, and preventive...

6th International Conference on Cardiology 2026

to invite you to this global gathering dedicated to advancing heart care and research. This conference serves as a platform for esteemed cardiologists, researchers, healthcare professionals, and industry leaders to convene and exchange...

Global Pharma Supply Chain & Logistics Forum 2026

Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...

2nd International Conference on Drug Discovery 2026

and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...

NextGen Pharma 2026

brings together scientists, researchers, industry leaders, regulators, and healthcare professionals to discuss transformative advancements in drug discovery, development, delivery systems, personalized medicine, and digital health. At NextGen...

Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma

to EU GMP standards, we can provide partners such as IPS Pharma with a consistent, reliable supply of dronabinol for oral formulations. This is how cannabinoid therapy becomes an accepted part of medicine rather than a category apart.” "We're...

Former DePuy Synthes U.S. President Joins Peptilogics Board

Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device...

Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories

Financial details were not disclosed. Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY scientific software into its agentic AI workflows. Atinary’s code-free SDLabs®...

AVANTIK Appoints Jeffrey Waldman as Chief Executive Officer

brings to Avantik more than two decades of healthcare leadership experience and a strong track record of building high-performing businesses. During a 19-year career at Henry Schein, he spearheaded strategic, operational and commercial initiatives...

BioVigil Reaches 1 Billion Hand Hygiene Opportunities, Marking a Major Milestone in Patient Safety and Infection Prevention

best practices, and support exceptional outcomes for our patients.” How verified hand hygiene works BioVigil has transformed how hospitals monitor and improve hand hygiene performance. The system captures HHOs using infrared beacons placed at...

Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models

Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions...

Takeda's ORZEYFUL™ Receives U.S. FDA Approval for Narcolepsy Type 1

pharmacy to U.S. healthcare providers and adults living with NT1. To sign up for updates visit ORZEYFUL.com. *For information regarding the submission of the new drug application for oveporexton to the U.S. FDA, please refer to Takeda’s press...

Why the Pharmacy System Rewards the Wrong Results: It Is Working as Designed

more reporting because greater visibility does not necessarily change what the system rewards. Manufacturers compete for formulary placement. PBMs negotiate rebates and administer benefits. Affiliated pharmacies earn revenue by dispensing...

Triquetra Health Launched BioActive Vitamin B1™—the First Complete B1 Activation System with a 600 mg Research-Matched Dose and Full Cofactor Support

Triquetra Health, a clinical-grade supplement company specializing in evidence-based formulation, announced the launch of BioActive Vitamin B1™ Clinical Strength, a complete B1 activation system delivering 600mg benfotiamine at the...

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

microbiome health company headquartered in Dallas, Texas, announced the launch of two of its science-backed microbiome formulas — resB® Lung Support Probiotic and resG prebeet® Prebiotic — at H-E-B stores across Texas. Founder and CEO Dr. C. Vivek...

US Capital Global Securities Announces $20 Million Offering for Thplasma to Invest in the Future of Plasma Therapeutics

$5 million venture debt facility. Thplasma is a U.S.-based pharmaceutical company operating an integrated human plasma platform spanning plasma collection, manufacturing, and commercialization. Through its network of FDA- and EMA-licensed plasma...

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths

is a global, research‐led pharmaceutical company with a unique focus on innovation and accessibility. We pioneer transformative breakthrough therapies that aim to redefine treatment while expanding access to high quality and affordable medicines...

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

and reliable delivery solutions increasingly important. EMS's semaglutide utilizes BD's established injection pen platform, which features an intuitive design built for ease of use. The BD Vystra™ Injection Pen platform reflects BD's deep expertise...

Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

Reed Upson, Senior Vice President, Asset-Based Lending at BOK Financial. "Excedr has built a highly differentiated platform, serving a diverse and high-quality customer base across the life sciences industry. Their strong OEM relationships,...